Dossier DOS-071
Dossier in NeeS format, version 7.1.7, for application TFDA-2024-0071. The module tree below shows the 5 CTD modules with their component count and status.
Dossier ID
DOS-071
Format
NeeS
Version
7.1.7
Status
Active
Application
Created
2022-05-14
Updated
2023-06-30
Total Modules
5
Module Tree
| Module | Title | Components | Status |
|---|---|---|---|
| 1 | Administrative Information and Prescribing Information | 14 | Draft |
| 2 | CTD Summaries | 6 | In Progress |
| 3 | Quality | 9 | Submitted |
| 4 | Nonclinical Study Reports | 8 | Failed |
| 5 | Clinical Study Reports | 9 | Blocked |
Content Components (showing first 20)
| ID | Section | Title | Version | Format | Words | Status | Owner |
|---|---|---|---|---|---|---|---|
| CC-071 | 1.5.7 | Proposed Conditions of Approval | 9.6 | HTML | 9,603 | Active | Dmitri Volkov |
| CC-171 | 1.3.7 | Application Form | 11.5 | 11,870 | Completed | Tomoko Ikeda | |
| CC-271 | 2.5.6 | Clinical Summary | 4.1 | XML | 10,002 | Failed | Nadia Petrova |
| CC-371 | 4.3.2 | Pharmacokinetics Studies | 5.5 | HTML | 13,582 | Submitted | Dmitri Volkov |
| CC-471 | 5.7.5 | Study Reports – Safety | 10.4 | 14,803 | Pending | Lieselotte van der Berg | |
| CC-571 | 2.7.5 | Clinical Summary | 4.2 | 3,636 | Approved | Nadia Petrova | |
| CC-671 | 5.2.4 | Integrated Summary of Safety | 7.1 | HTML | 4,377 | Draft | Marcus Webb |
| CC-771 | 1.5.6 | Prescribing Information | 4.4 | 1,711 | Overdue | Sarah Chen | |
| CC-871 | 3.1.6 | Manufacturing Process | 8.1 | 14,443 | Failed | Aisha Okonkwo | |
| CC-971 | 4.2.7 | Carcinogenicity | 1.9 | 13,624 | Pending | Nadia Petrova | |
| CC-1071 | 5.2.6 | Integrated Summary of Efficacy | 11.7 | XML | 5,099 | In Progress | Marcus Webb |
| CC-1171 | 4.2.5 | Toxicology Studies | 10.4 | 3,089 | Failed | Priya Sharma | |
| CC-1271 | 4.2.9 | Toxicology Studies | 9.1 | Word | 2,592 | Submitted | Aisha Okonkwo |
| CC-1371 | 1.7.4 | Proposed Conditions of Approval | 12.6 | 8,018 | Blocked | Sarah Chen | |
| CC-1471 | 5.4.1 | Integrated Summary of Efficacy | 11.2 | Word | 2,430 | Failed | Nadia Petrova |
| CC-1571 | 3.6.1 | Drug Substance | 7.9 | HTML | 2,525 | Failed | Nadia Petrova |
| CC-1671 | 4.2.3 | Pharmacokinetics Studies | 6.7 | HTML | 7,957 | Pending | James O'Brien |
| CC-1771 | 1.8.6 | Proposed Conditions of Approval | 4.1 | Word | 10,468 | Active | Nadia Petrova |
| CC-1871 | 5.2.7 | Study Reports – Efficacy | 2.9 | Word | 4,592 | Pending | Sarah Chen |
| CC-1971 | 5.7.2 | Integrated Summary of Safety | 8.3 | 5,806 | Overdue | Dmitri Volkov |
Showing 20 of 20 components